Compare · CERS vs DASH
CERS vs DASH
Side-by-side comparison of Cerus Corporation (CERS) and DoorDash Inc. (DASH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CERS and DASH operate in EDP Services (Technology), so they compete in similar markets.
- DASH is the larger of the two at $35.57B, about 68.3x CERS ($521.0M).
- Over the past year, CERS is up 75.7% and DASH is down 28.3% - CERS leads by 103.9 points.
- DASH has been more active in the news (18 items in the past 4 weeks vs 12 for CERS).
- DASH has more recent analyst coverage (25 ratings vs 4 for CERS).
- Company
- Cerus Corporation
- DoorDash Inc.
- Price
- $2.60-0.19%
- $156.01+2.34%
- Market cap
- $521.0M
- $35.57B
- 1M return
- -0.57%
- -4.78%
- 1Y return
- +75.68%
- -28.27%
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 1997
- News (4w)
- 12
- 18
- Recent ratings
- 4
- 25
Cerus Corporation
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation has collaboration with LifeSouth Community Blood Centers to manufacture INTERCEPT Fibrinogen Complex. The company was incorporated in 1991 and is headquartered in Concord, California.
DoorDash Inc.
DoorDash, Inc. operates a logistics platform that connects merchants, consumers, and dashers in the United States and internationally. It operates DoorDash marketplace, which provides an array of services that enable merchants to solve mission-critical challenges, such as customer acquisition, delivery, insights and analytics, merchandising, payment processing, and customer support; and offers DoorDash Drive, a white-label logistics service; DoorDash Storefront that enables merchants to offer consumers on-demand access to e-commerce. The company was formerly known as Palo Alto Delivery Inc. and changed its name to DoorDash, Inc. in 2015. DoorDash, Inc. was founded in 2013 and is headquartered in San Francisco, California.
Latest CERS
- Cerus Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation
- Cerus Corporation Closes New Debt Facility of Up to $110 Million
- Cerus Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders
- Director Lucena Ann was granted 60,000 shares, increasing direct ownership by 35% to 232,284 units (SEC Form 4)
- Director Bjerkholt Eric was granted 60,000 shares, increasing direct ownership by 27% to 282,133 units (SEC Form 4)
- Director Nachtsheim Jami K was granted 60,000 shares, increasing direct ownership by 29% to 268,362 units (SEC Form 4)
- Chief Operating Officer Jayaraman Vivek K sold $50,001 worth of shares (16,667 units at $3.00) as part of a pre-agreed trading plan, decreasing direct ownership by 1.00% to 1,656,707 units (SEC Form 4)
- Director Witney Frank was granted 60,000 shares, increasing direct ownership by 21% to 340,059 units (SEC Form 4)
- Director Gregory Dean A. was granted 60,000 shares, increasing direct ownership by 69% to 146,725 units (SEC Form 4)
- Director Shan Hua was granted 60,000 shares, increasing direct ownership by 45% to 192,386 units (SEC Form 4)
Latest DASH
- Director Kovac Milan bought $6,237 worth of shares (40 units at $155.94), increasing direct ownership by 2% to 1,942 units (SEC Form 4)
- Director Tang Stanley acquired 23,125 shares as part of a pre-agreed trading plan and sold $3,646,189 worth of shares (23,125 units at $157.67) as part of a pre-agreed trading plan (SEC Form 4)
- DoorDash Ads Becomes a Global Commerce Media Platform
- CHIEF BUSINESS OFFICER Yandell Keith sold $410,576 worth of shares (2,643 units at $155.34) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 81,106 units (SEC Form 4)
- PRESIDENT AND COO Adarkar Prabir exercised 10,000 shares at a strike of $7.16 and sold $3,375,042 worth of shares (21,739 units at $155.25) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 959,076 units (SEC Form 4)
- DoorDash, Deliveroo and Wolt Debut First-Ever International Campaign Celebrating the FIFA World Cup 2026™
- Summer of DashPass Is Back to Help Fans Make the Most of FIFA World Cup 2026™
- DoorDash and Dollar Tree Partner to Bring Greater Value and Thrill of the Hunt Discovery On-Demand
- GENERAL COUNSEL AND SECRETARY Sherringham Tia sold $441,047 worth of shares (2,743 units at $160.79) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 128,216 units (SEC Form 4)
- CHIEF ACCOUNTING OFFICER Lee Gordon S exercised 2,000 shares at a strike of $17.57 and sold $354,381 worth of shares (2,204 units at $160.79) as part of a pre-agreed trading plan, decreasing direct ownership by 0.23% to 89,447 units (SEC Form 4)